Shares of Milestone Therapeutics MIST fell 21.67% during market hours on Oct 17, after rising 41% in premarket, post the company’s announcement of top-line results from a late-stage study evaluating ...
Shares of small-cap Milestone Pharmaceuticals Inc MIST were losing three-quarters of their value Tuesday on the back of a negative clinical readout. Milestone, which went public in mid-2019, said a ...
You may never have heard of muons before, but these particles are crucial to our understanding of the universe. In a milestone study published Wednesday in the journal Nature, researchers announce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback